CD147 is critical for cancer stem cell chemoresistance: what does this mean for the clinic?

被引:2
|
作者
Kim, Kristine M. [1 ,2 ]
Yi, Eugene C. [3 ,4 ,5 ]
机构
[1] Kangwon Natl Univ, Coll Biomed Sci, Dept Syst Immunol, Kangwon, South Korea
[2] Kangwon Natl Univ, Inst Antibody Res, Kangwon, South Korea
[3] Seoul Natl Univ, Sch Convergence Sci & Technol, WCU Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Seoul, South Korea
[5] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
关键词
cancer stem cell; CD147; basigin; EMMPRIN; drug resistance; targeted therapy; MONOCARBOXYLATE TRANSPORTERS; LUNG-CANCER; RESISTANCE; EMMPRIN; GROWTH;
D O I
10.1586/14789450.2013.814936
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:313 / 315
页数:3
相关论文
共 50 条
  • [21] CD147: an integral and potential molecule to abrogate hallmarks of cancer
    Nyalali, Alphonce M. K.
    Leonard, Angela U.
    Xu, Yongxiang
    Li, Huayu
    Zhou, Junlin
    Zhang, Xinrui
    Rugambwa, Tibera K.
    Shi, Xiaohan
    Li, Feng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] On the role of EMMPRIN (CD147) in pancreas cancer progression.
    Bachem, MG
    Fundel, M
    Sehuenemann, M
    Raiche, N
    Gruenert, A
    CLINICAL CHEMISTRY, 2003, 49 (06) : A100 - A100
  • [23] CD147 expression lacks prognostic relevance in esophageal cancer
    Natalie Küsters
    Katharina Grupp
    Julia-Kristin Grass
    Kai Bachmann
    Tarik Ghadban
    Faik G. Uzunoglu
    Michael Tachezy
    Daniel Perez
    Matthias Reeh
    Jakob R. Izbicki
    Nathaniel Melling
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 837 - 844
  • [24] CD147 expression in advanced cutaneous squamous cell carcinoma
    Sweeny, Larissa
    Dean, Nichole R.
    Frederick, John W.
    Magnuson, J. Scott
    Carroll, William R.
    Desmond, Renee A.
    Rosenthal, Eben L.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2012, 39 (06) : 603 - 609
  • [25] CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
    Henning Ulrich
    Micheli M. Pillat
    Stem Cell Reviews and Reports, 2020, 16 : 434 - 440
  • [26] CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
    Ulrich, Henning
    Pillat, Micheli M.
    STEM CELL REVIEWS AND REPORTS, 2020, 16 (03) : 434 - 440
  • [27] EMMPRIN (CD147) confers cancer cell resistance to anoikis through inhibition of bim induction
    Yang, Jinming
    O'neill, Peter
    Jin, Wei
    Medina, Daniel J.
    Foty, Ramsey
    Lomas, Mehnaaz
    Arndt, Greg M.
    Tang, Yi
    Nakada, Marian
    Yan, Li
    Hait, William N.
    CANCER RESEARCH, 2006, 66 (08)
  • [28] CD147 dependant intrahepatic immune and cancer cell aggregation; a novel mechanism of liver injury
    Morgan, Alison J.
    Maczurek, Annette E.
    Calabro, Sarah N.
    Mccaughan, Geoffrey
    Warner, Fiona J.
    Mclennan, Susan V.
    Shackel, Nicholas
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 11 - 11
  • [29] Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147
    Li, M
    Zhai, QH
    Bharadwaj, U
    Wang, H
    Li, F
    Fisher, WE
    Chen, CY
    Yao, QZ
    CANCER, 2006, 106 (10) : 2284 - 2294
  • [30] Cluster of differentiation 147 (CD147) as potential membrane protein biomarker for bladder cancer cells
    Roslan, Adlina
    Said, Diana Suhaiza
    Sulaiman, Nurshahira
    Ghani, Khairul Asri Mohd
    Nurdin, Armania
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 236